David E. Neal
Researcher Next ID · RN-031844
Researcher · Biochemistry, Genetics and Molecular Biology
Oxford, United Kingdom
- Works count
- 1,277
- Citation count
- 68,672
- H-index
- 124
- i10-index
- 580
Research interests
Publications
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
Nature Genetics · 2023 · https://doi.org/10.1038/s41588-023-01534-4
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2214122
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Nature Genetics · 2021 · https://doi.org/10.1038/s41588-020-00748-0
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Nature Genetics · 2018 · https://doi.org/10.1038/s41588-018-0142-8
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
BMJ · 2018 · https://doi.org/10.1136/bmj.j5757
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1606220
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1606221
Mutational signatures of ionizing radiation in second malignancies
Nature Communications · 2016 · https://doi.org/10.1038/ncomms12605
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-15-1227
Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
JNCI Journal of the National Cancer Institute · 2015 · https://doi.org/10.1093/jnci/djv095
The evolutionary history of lethal metastatic prostate cancer
Nature · 2015 · https://doi.org/10.1038/nature14347
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
EBioMedicine · 2015 · https://doi.org/10.1016/j.ebiom.2015.07.017
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)71021-6
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Nature Genetics · 2013 · https://doi.org/10.1038/ng.2560
A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer
Nature Genetics · 2012 · https://doi.org/10.1038/ng.2437
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Nature Genetics · 2011 · https://doi.org/10.1038/ng.882
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
Nature Genetics · 2009 · https://doi.org/10.1038/ng.450
Multiple loci on 8q24 associated with prostate cancer susceptibility
Nature Genetics · 2009 · https://doi.org/10.1038/ng.452
Multiple newly identified loci associated with prostate cancer susceptibility
Nature Genetics · 2008 · https://doi.org/10.1038/ng.90
Multiple Loci With Different Cancer Specificities Within the 8q24 Gene Desert
JNCI Journal of the National Cancer Institute · 2008 · https://doi.org/10.1093/jnci/djn190
Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
Health Technology Assessment · 2003 · https://doi.org/10.3310/hta7140
Quality improvement report Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study Commentary: presenting unbiased information to patients can be difficult
BMJ · 2002 · https://doi.org/10.1136/bmj.325.7367.766
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.
PubMed · 1993
Current projects
No projects listed.